未登录

Q

Qingxian Cai

sun yatsen university

H指数:17

被引数:4,679

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Constructing an immune-related prognostic signature for predicting prognosis and immune response in hepatocellular carcinoma

构建预测肝细胞癌预后和免疫应答的免疫相关预后签名

IF3.6

2024-07-010

OAAI

Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update

HEPATOLOGY INTERNATIONAL

IF6.1

2024-02-249

PRE

PPP2R2A promotes testosterone secretion in Hu sheep Leydig cells via activation of the AKT/mTOR signaling pathway

JOURNAL OF MOLECULAR ENDOCRINOLOGY

IF3.8

2023-03-084

PRE

Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury

clinical and translational gastroenterology

IF4.2

2022-05-205

OAAI

Dysregulated hematopoiesis in bone marrow marks severe COVID-19

骨髓造血功能失调标志着严重的新型冠状病毒肺炎

IF12.5

2021-08-0450

OAAI

Acute Kidney Injury and Early Predictive Factors in COVID-19 Patients

新型冠状病毒肺炎患者急性肾损伤及早期预测因素分析

FRONTIERS IN MEDICINE

IF3

2021-07-121

OAAI

Three-Month Pulmonary Function and Radiological Outcomes in COVID-19 Survivors: A Longitudinal Patient Cohort Study

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2020-11-147

OAAI

Reply to: Liver tests abnormalities in COVID-19: trick or treat?

JOURNAL OF HEPATOLOGY

IF33

2020-11-014

OAAI

RETRACTED: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (Retracted Article)

IF11.6

2020-10-01950

OAAI

Response to Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398

IF16.6

2020-09-112

OAAI

COVID-19: Abnormal liver function tests

JOURNAL OF HEPATOLOGY

IF33

2020-09-01710

OAAI

Reply to: Clinical characteristics of COVID-19 patients with abnormal liver tests

JOURNAL OF HEPATOLOGY

IF33

2020-09-014

OAAI

Longitudinal changes of liver function and hepatitis B reactivation in COVID-19 patients with pre-existing chronic hepatitis B virus infection

HEPATOLOGY RESEARCH

IF3.4

2020-08-2973

OAAI

Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China

IF16.6

2020-05-14458

PREAI

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China

IF12

2020-04-17348

OAAI

The effects of direct-acting antiviral agents on the frequency of myeloid-derived suppressor cells and natural killer cells in patients with chronic hepatitis C

直接抗病毒药物对慢性丙型肝炎患者髓源性抑制细胞和自然杀伤细胞频率的影响

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2018-09-2410

PREAI

An outbreak of HCV genotype 6a and 2a infection in South China: Confirmation of iatrogenic transmission by phylogenetic analysis of the NS5B region

MOLECULAR MEDICINE REPORTS

IF3.5

2016-09-132

OA

Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2013-05-227

PREAI

Comparison of three different HCV genotyping methods: Core, NS5B sequence analysis and line probe assay

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

IF5.8

2012-12-1267

OAAI

Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype

VIROLOGY JOURNAL

IF3.8

2012-06-1920

OAAI